Literature DB >> 23832327

Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population.

Naoki Shiraishi1, Kenichiro Kitamura, Yukimasa Kohda, Kunitoshi Iseki, Kimio Tomita.   

Abstract

BACKGROUND: Nephrosclerosis/ischemic nephropathy (NS/IN) ranks third among renal diseases requiring dialysis in Japan. Although it is an important renal disease in terms of frequency, its prevalence, new incidence, and risk factors are not fully elucidated.
METHODS: We analyzed the prevalence, incidence, concurrent diseases, and risk factors of NS/IN by using data from specific health checkups of Kumamoto citizens between 2008 and 2010.
RESULTS: Although the prevalence of NS/IN was 1-2 % in people in their 40s, it increased sharply with age, reaching 17.6 % in people aged 70-74 years. The incidence of new NS/IN was 0.4-0.5 % per year. In multivariate logistic regression analysis, factors such as age, male gender, body mass index (BMI), hyperuricemia, hypertension, and dyslipidemia correlated with NS/IN. When risk factors associated with NS/IN progress were evaluated by multivariate logistic regression analysis, four factors-male gender, hypertension, BMI, and current smoking-significantly correlated.
CONCLUSION: The analysis of Kumamoto citizens aged 40-74 years receiving specific health checkups showed that in addition to hypertension and age that were considered important, male gender and obesity are also risk factors for NS/IS independent from hypertension.

Entities:  

Mesh:

Year:  2013        PMID: 23832327     DOI: 10.1007/s10157-013-0833-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

Review 1.  [Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome].

Authors: 
Journal:  Nihon Naika Gakkai Zasshi       Date:  2005-04-10

2.  Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

Authors:  K Yamagata; K Ishida; T Sairenchi; H Takahashi; S Ohba; T Shiigai; M Narita; A Koyama
Journal:  Kidney Int       Date:  2006-11-22       Impact factor: 10.612

3.  Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.

Authors:  C Y Hsu
Journal:  J Hum Hypertens       Date:  2001-02       Impact factor: 3.012

Review 4.  Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.

Authors:  Rafael Marín; Manuel Gorostidi; Francisco Fernández-Vega; Rafael Alvarez-Navascués
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

5.  Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Taku Inoue; Chiho Iseki; Kozen Kinjo; Shuichi Takishita
Journal:  Am J Kidney Dis       Date:  2004-10       Impact factor: 8.860

6.  Prevalence of chronic kidney disease in the Japanese general population.

Authors:  Enyu Imai; Masaru Horio; Tsuyoshi Watanabe; Kunitoshi Iseki; Kunihiro Yamagata; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Toshiki Moriyama; Yasuhiro Ando; Shoichi Fujimoto; Tsuneo Konta; Hitoshi Yokoyama; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-11       Impact factor: 2.801

7.  Does treated essential hypertension result in renal impairment? A cohort study.

Authors:  C R Tomson; K Petersen; A M Heagerty
Journal:  J Hum Hypertens       Date:  1991-06       Impact factor: 3.012

Review 8.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 9.  Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

Authors:  Lilach O Lerman; Stephen C Textor; Joseph P Grande
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  3 in total

1.  Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.

Authors:  Aleksandar Denic; Mariam P Alexander; Vidhu Kaushik; Lilach O Lerman; John C Lieske; Mark D Stegall; Joseph J Larson; Walter K Kremers; Terri J Vrtiska; Harini A Chakkera; Emilio D Poggio; Andrew D Rule
Journal:  Am J Kidney Dis       Date:  2016-02-06       Impact factor: 8.860

2.  Prediction model of compensation for contralateral kidney after living-donor donation.

Authors:  Kenji Okumura; Shigeyoshi Yamanaga; Kosuke Tanaka; Kohei Kinoshita; Akari Kaba; Mika Fujii; Masatomo Ogata; Yuji Hidaka; Mariko Toyoda; Soichi Uekihara; Akira Miyata; Akito Inadome; Hiroshi Yokomizo
Journal:  BMC Nephrol       Date:  2019-07-26       Impact factor: 2.388

Review 3.  Acute kidney injury and the compensation of kidney function after nephrectomy in living donation.

Authors:  Kenji Okumura; Holly Grace; Hiroshi Sogawa; Shigeyoshi Yamanaga
Journal:  World J Transplant       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.